Wealth Enhancement Advisory Services’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.18M | Buy |
20,678
+34
| +0.2% | +$3.59K | ﹤0.01% | 1311 |
|
2025
Q1 | $2.41M | Buy |
20,644
+1,017
| +5% | +$119K | ﹤0.01% | 1150 |
|
2024
Q4 | $1.66M | Sell |
19,627
-181
| -0.9% | -$15.3K | ﹤0.01% | 1263 |
|
2024
Q3 | $1.78M | Buy |
19,808
+754
| +4% | +$67.8K | ﹤0.01% | 1113 |
|
2024
Q2 | $1.53M | Buy |
19,054
+9
| +0% | +$725 | ﹤0.01% | 1097 |
|
2024
Q1 | $1.52M | Buy |
19,045
+130
| +0.7% | +$10.4K | ﹤0.01% | 1068 |
|
2023
Q4 | $1.51M | Buy |
+18,915
| New | +$1.51M | ﹤0.01% | 1001 |
|